Emodin (9) downregulates serum IL-1 and TNF-α secretion and exerts anti-NAFLD effects by inhibiting the hepatic TLR4 signaling pathway (Tao et al., 2017). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.